It was found that SPL treatment prevented diabetes-induced loss of cldn-5 (Fig 2A and 2B) in GL, and cldn-2 (Fig 2A and 2C) and occldn (Fig 2A and 2D) in PT evaluated by IB. The gene discussed is CLDN2; the disease is diabetes mellitus.